US BANCORP \DE\ - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$3,427
+97.5%
157
+185.5%
0.00%
Q4 2022$1,735550.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q1 2023
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders